Related Articles
HUMAN ONCOPROTEIN MDM2 INTERACTS WITH THE TATA-BINDING PROTEIN IN-VITRO AND IN-VIVO
The human oncoprotein MDM2 uses distinct strategies to inhibit transcriptional activation mediated by the wild-type p53 and its tumor-derived mutants
Disruption of functions of wild-type p53 by hetero-oligomerization.
Differential modulatation of cellular and viral promoters by p73 and p53
T-ANTIGEN OF SV40 BLOCKS P53 TRANSACTIVATION BUT NOT P53 SPECIFIC BINDING TO DNA